COX2-derived primary and cyclopentenone prostaglandins are increased after asphyxial cardiac arrest

Brain Research

Volumn 1519, Issue , 2013, Pages 71-77

  Liu, Hao ^a,b   Rose, Marie E ^a,b   Miller, Tricia M ^c   Li, Wenjin ^a,b   Shinde, Sunita N ^b   Pickrell, Alicia M ^b   Poloyac, Samuel M ^c   Graham, Steven H ^a,b   Hickey, Robert W ^b  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cardiac arrest; Cyclooxygenase; Cyclopentenone; Hypoxic ischemia; Prostaglandin

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; CYCLOOXYGENASE 2; CYCLOPENTENONE; PROSTAGLANDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; HEART ARREST; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MASS SPECTROMETRY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESUSCITATION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ASPHYXIA; BRAIN ISCHEMIA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; HEART ARREST; HIPPOCAMPUS; IN SITU NICK-END LABELING; MALE; MASS SPECTROMETRY; PROSTAGLANDINS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION;

RATTUS;

EID: 84878759705     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.04.029     Document Type: Article

References (27)

1. M. Amer Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale Cardiol. Rev. 18 2010 204 212
2. K. Andreasson Prostaglandin signalling in cerebral ischaemia Br. J. Pharmacol. 160 2010 844 846
3. L.C. Bell-Parikh Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma J. Clin. Invest. 112 2003 945 955
4. S.A. Brose, B.T. Thuen, and M.Y. Golovko LC/MS/MS method for analysis of E2 series prostaglandins and isoprostanes J. Lipid. Res. 52 2011 850 859
5. E. Candelario-Jalil Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats J. Neurochem. 100 2007 1108 1120
6. E. Candelario-Jalil, and B.L. Fiebich Cyclooxygenase inhibition in ischemic brain injury Curr. Pharm. Des. 14 2008 1401 1418
7. E.L. Fink Experimental model of pediatric asphyxial cardiopulmonary arrest in rats Pediatr.Crit. Care Med. 5 2004 139 144
8. B. Garzon Proteomic studies on protein modification by cyclopentenone prostaglandins: expanding our view on electrophile actions J. Proteomics 74 2011 2243 2263
9. S.J. Hewett, S.C. Bell, and J.A. Hewett Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system Pharmacol. Ther. 112 2006 335 357
10. R.W. Hickey Cyclooxygenase-2 activity following traumatic brain injury in the developing rat Pediatr. Res. 2007 271 276
11. A. Higdon Cell signalling by reactive lipid species: new concepts and molecular mechanisms Biochem. J. 442 2012 453 464
12. C. Iadecola Reduced susceptibility to ischemic brain injury and N-methyl-D- aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice Proc. Natl. Acad. Sci. USA 98 2001 1294 1299
13. C. Iadecola, and P.B. Gorelick The Janus face of cyclooxygenase-2 in ischemic stroke: shifting toward downstream targets Stroke 36 2005 182 185
14. L.M. Koharudin Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1 Proc. Natl. Acad. Sci. USA 107 2010 6835 6840
15. M. Kondo 15-Deoxy-delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis Proc. Natl. Acad. Sci. USA 99 2002 7367 7372
16. A.L. Levonen Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products Biochem. J. 378 2004 373 382
17. H. Liu Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury Neurobiol. Dis. 2010
18. T.M. Miller Rapid, simultaneous quantitation of mono and dioxygenated metabolites of arachidonic acid in human CSF and rat brain J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 877 2009 3991 4000
19. M. Nakayama Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia Proc. Natl. Acad. Sci. USA 95 1998 10954 10959
20. S. Nogawa Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage J. Neurosci. 17 1997 2746 2755
21. S. Nogawa Interaction between inducible nitric oxide synthase and cyclooxygenase- 2 after cerebral ischemia Proc. Natl. Acad. Sci. USA 95 1998 10966 10971
22. W.S. Powell 15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? J. Clin. Invest. 112 2003 828 830
23. F.J. Sanchez-Gomez Protein thiol modification by 15-deoxy-Delta12,14- prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes Mol. Pharmacol. 66 2004 1349 1358
24. T. Satoh, and S.A. Lipton Redox regulation of neuronal survival mediated by electrophilic compounds Trends Neurosci. 30 2007 37 45
25. S. Takei Immunohistochemical demonstration of increased prostaglandin F(2)alpha levels in the rat hippocampus following kainic acid-induced seizures Neuroscience 218 2012 295 304
26. H. Taniguchi Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury J. Neurosci. 27 2007 4303 4312
27. K. Uchida, and T. Shibata 15-Deoxy-delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses Chem. Res. Toxicol. 21 2008 138 144